Author:
Goel Amit,Amar Arvind,Gondaliya Binal
Publisher
Jaypee Brothers Medical Publishing
Reference6 articles.
1. 1. WHO. Global Leaders Group on antimicrobial resistance. 2021.
2. 2. WHO. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. 2017.
3. 3. Shigemoto N, Kuwahara R, Kayama S, et al. Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6. Diagn Microbiol Infect Dis 2012;72(1):109–112. DOI: 10.1016/j.diagmicrobio.2011.09.019
4. 4. Kouda S, Ohara M, Onodera M, et al. Increased prevalence and clonal dissemination of multidrug-resistant iPseudomonas aeruginosa/i with the blasubIMP-1/sub gene cassette in Hiroshima. J Antimicrob Chemother 2009;64(1):46–51. DOI: 10.1093/jac/dkp142
5. 5. Barenfanger J, Drake C, Karich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 1999;37(5):1415–1418. DOI: 10.1128/JCM.37.5.1415-1418.1999